EXAS Exact Sciences Corporation
Healthcare$104.91+0.00%ClosedMarket Cap: $20.03B
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$105.00
Target (Median)
$105.00
Target Range
$105.00 - $105.00
Upside from current price: 0.1%
Rating Distribution
1 Strong Buy1 Buy20 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-01-20 | Mizuho | downgrade | Neutral | Outperform |
| 2026-01-05 | Evercore ISI Group | downgrade | In Line | Outperform |
| 2025-11-28 | Stifel | downgrade | Hold | Buy |
| 2025-11-25 | Canaccord Genuity | downgrade | Hold | Buy |
| 2025-11-24 | Jefferies | downgrade | Hold | Buy |
| 2025-11-24 | Benchmark | downgrade | Hold | Buy |
| 2025-11-21 | Wells Fargo | downgrade | Equal Weight | Overweight |
| 2025-11-21 | William Blair | downgrade | Market Perform | Outperform |
| 2025-11-21 | Barclays | downgrade | Equal Weight | Overweight |
| 2025-11-21 | Guggenheim | downgrade | Neutral | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $1.09 | $4.18B | 3 |
| Sun Dec 31 | $1.74 | $4.60B | 5 |
| Mon Dec 31 | $2.09 | $4.93B | 1 |
| Tue Dec 31 | $3.13 | $5.12B | 1 |